维普期刊资源整合服务平台（V6.5）

82篇 您的检索式：作者名="HUDIS C"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Cardiac dysfunction in the trastuzumab clinical trials experience显示文摘	Seidman A Hudis C Pierri MK	2002	J Clin Oncol2002，20，5：	1
2	Advances in adjuvant chemotherapy of early stage breast cancer显示文摘	McArthur H L and Hudis C A	2008	Cancer Treat Res2008，141，：	1
3	Cardiac dysfunction in the trastuzumab clinical trials experience显示文摘	Seidman A Hudis C Pierri MK	2002	J Clin Oncol2002，20，5：	1
4	American society of clinical oncology technology assessment on the use of aromotase inhibitors as adjuvant theraphy for postmenopausal women with hormone receptor-positive breast cancer:status report 2004显示文摘	Winer EP Hudis C Burstein HJ	2005	J Clin Oncol2005，23，3：	1
5	Phase Ⅱ evaluation of taxotere (RP 56976, NSC 628503) as initial chemotherapy for metastatic breast cancer 显示文摘	Seidman AD Hudis C Crown JPA	1993	Proc Am Soc Clin Oncol1993，12，：	1
6	American society of clinic-oncology technology assessment on the use of aromotasein hibitors as adjuvant theraphy for postmenopausal women with hormone receptor-positive breast cancer status report显示文摘	Winer EP Hudis C Burstein HJ	2005	ClinOncol2005，23，3：	1
7	American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer:Status report 2004显示文摘	Winer EP Hudis C Burstein HJ	2005	J Clin Oncol2005，23，3：	1
8	New approaches to adjuvant chemotherapy for breast cancer显示文摘	Hudis C	1996	Pharmaco Therapy1996，16，32：	1
9	Adjuvant therapy for breast cancer: practical lessons from the early breast cancer trialists'collaborative group显示文摘	Hudis C A Dang O T	2004	Breast Dis2004，21，：	1
10	Cardiac dysfunction in the trastuzumab clinical trials experience 显示文摘	Seidman A Hudis C Pierri MK	2002	J Clin Oncol2002，20，5：	1
11	Cardiac dyshunction in the trastuzumab clinical trial experience 显示文摘	Seidman A Hudis C Pierri MK	2002	J Clin Oncol2002，20，5：	1
12	Spin Resonance in the d -Wave Superconductor CeColn5 显示文摘	Stock C Broholm C Hudis J	2008	Phys Rev Lett2008，100，08：	1
13	Cardiac dysfunction in the trastuzumab clinical trials experience显示文摘	Seidman A Hudis C Pierri MK	2002	J Clin Oncol2002，20，5：	1
14	American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors as Adjuvant Therapy for Women With Hormone ReceptorPositive Breast Cancer: Status Report 2002显示文摘	Hudis C Burstein H J	2002	J Clin Oncol2002，20，：	1
15	Cardiac profiles of liposomal anthracyclines:greater cardiac safety versus conventional doxorubicin ?显示文摘	Theodoulou M Hudis C	2004	Cancer2004，100，10：	1
16	Phase Ⅱ trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer显示文摘	Seidman AD Tiersten A Hudis C	1995	J Clin Oncol1995，13，10：	1
17	American society of clinical oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004 显示文摘	WINER E P HUDIS C BURSTEIN H J	2005	J Clin Oncl2005，23，3：	1
18	American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004 显示文摘	Winer EP Hudis C Burstein HJ	2005	J Clin Oncol2005，23，3：	1
19	Five year follow-up if INT C9741:dose-dense chemotherapy is safe and effective显示文摘	Hudis C Citron M Berry D	2005	Breast Cancer Res Treat2005，94，6：	1
20	New approaches to adjuvant chemotherapy for breastcancer显示文摘	Hudis C	1996	Pharmacotherapy1996，16，32：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示